INTRODUCTION
Glaucoma is a heterogeneous group of conditions involving cupping and atrophy of the optic nerve, characteristic visual field loss and often but not invariably a high intraocular pressure. 1 Different populations tend to suffer from different types of glaucoma. The chronic simple glaucoma is the more common form of the disease in our environment (and generally in people of African descent), while the closed angle form of the disease is more common in people of Asian descent. 1, 2 Glaucoma is the third largest cause of blindness worldwide after cataract and trachoma. WHO estimates that about 105 million people suffer from glaucoma around the world, and an estimated 5.2 million are blind from it. 1 It has been found that 24% of sufferers of chronic simple glaucoma were blind in at least one eye. 3 This is because there is no reliable and cost-effective way of 
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detecting and treating the disease in large populations. The burden of blindness from the different types of glaucoma is high. Therefore, making a diagnosis of a serious eye disease such as glaucoma, which can lead to blindness, usually has an emotional impact on the patient. Just as psychosocial stress can translate into illnesses that warrant treatment, 4 so do some physical illnesses also create psychological sequelae that precipitate psychiatric disorders severe enough to require specialist treatment. However, a large majority of patients with physical disorder including glaucoma suffer from hidden psychiatric disorders that are often undetected by their attending primary care physicians. 5 Depression and anxiety constitute greater percentage of these common co-morbid psychiatric disorders in physically ill patients. 5, 6 No previous research report in this locale has addressed this problem among glaucoma patients.
The aim of this study was to evaluate glaucoma patients to ascertain the prevalence of psychiatric disorders, particularly anxiety and depression. Secondly, to delineate the socio-demographic characteristics of glaucoma patients with co-morbid psychiatric disorders.
MATERIALS AND METHODS

Study population
Subjects for this study were recruited from among patients attending the glaucoma clinic at the Consultant Outpatient Department of the University of Benin Teaching Hospital (UBTH) between July and December 2002. Only those patients who gave verbal consent to participate in the study and were diagnosed as suffering from uncomplicated open angle glaucoma by the specialist ophthalmologists were included. All glaucoma patients with coexisting ocular pathology such as media opacities, retina and macular diseases were excluded.
Measures
Two main questionnaires were used for this study as measures of general psychiatric morbidity, and anxiety and depression. The 20-item self-reporting questionnaire (SRQ-20) is a World Health Organization (WHO) psychometric instrument for measuring the level of psychiatric morbidity in primary health care settings. Its norms for use among Nigerian patient populations are wellestablished, with a cut-off score of five or more discriminating between cases and noncases of psychiatric disorders among Nigerian patients. The instrument has a sensitivity of 95.8%, a specificity of 90.9% and a minimum misclassification rate of 7.9%. 7 The hospital anxiety and depression scale (HADS) developed by Zigmond and Snaith in 1983 is a 14-item instrument especially designed for use among non-psychiatric patients. It consists of seven items each for anxiety and depression, rated on a four-point scale of severity. The instrument is devoid of somatic symptoms, hence its usefulness in assessing the impact of physical illness on psychological well being. Its utility among widely varied Nigerian patients' populations and the established norms informed the choice of this instrument.
8 Design A two-stage prospective case identification technique was adopted for the study.
Procedure
All new referrals to the glaucoma clinic during the study period were evaluated by the ophthalmologist authors. Patients that met the inclusion criteria for the study were then asked to see the trained research assistant in the adjoining room. Each patient was first assessed using the SRQ-20. Those with a score of five or more were subsequently interviewed using the HADS instrument. On the average, it took 25 minutes to administer both que-stionnaires. The demographic characteristics consisting of age, sex, marital status, level of education and occupation were obtained from the patients using a separate data collection sheet. Simple descriptive statistics was adopted for data analysis using the Student's t and the chi-square tests where appropriate. Significant probability level was set at p < 0.05. Table  1 shows the age and sex distribution of the group. It is noteworthy that the vast majority (76%) were aged 50 years or above and that the elderly population aged 60 years or above constituted 52% of the study group. Other socio-demographic features of the study group are as shown in Tables 2 and 3. Eleven (22%) patients in the study group with a mean age of 49.09 years and comprising seven males and four females scored > 5 on the SRQ-20, thus giving a probable psychiatric morbidity prevalence rate of 22%. The hospital anxiety and depression scale identified five of the cases as suffering from probable anxiety disorder, three as probable cases of depressive disorder, while the remaining three failed to meet the cut-off score for either diagnostic category. Thus, the study group had probable prevalence rates of 10% and 6% respectively for anxiety and depressive disorders. Table 4 summarises the socio-demographic characteristics and psychometric test scores of the eleven cases identified by the SRQ-20. Lack of formal education was the only factor identified to be associated with the presence of psychiatric morbidity (SRQ-20 > 5) and significantly distinguished the cases from non-cases (Fisher's exact χ 2 = 20.891, df = 3, p < 0.0075). The eleven cases scored significantly higher than the non-cases in all psychometric measures. Although the four female cases identified had a mean age of 56.0 + 19.4 years as against 45.1 + 18.8 years for the seven male cases, the difference was not statistically significant (t = 0.8026, df = 9, p > 0.05). Seven of the eleven identified cases were aged 50 years and above as against four aged less than 50 years. The cases aged 50 years and above were significantly more depressed than those below 50 years (mean HADS depression score of 7.5 + 3.05 versus 4.0 + 2.16; t = 2.0284, df = 9, p < 0.05). The reverse was the case with their performance on the anxiety axis of the test instrument (> 50 years versus < 50 years test scores were 5.17 + 2.97 versus 10.0 + 0.5, t = 3.22, p < 0.01).
RESULTS
Fifty subjects comprising
34 males and 16 females with a male:female ratio of 2.1:1 and an age range of 16 to 92 years (mean 57.3 + 39.2 years) were recruited for the study.
DISCUSSION
Long-term treatment of chronic illnesses could be stressful for patients. For patients with open angle glaucoma, apart from frequent and multiple hospital visits, cost of drugs, transportation and other expenses connected with management, there is also the fear of losing vision, which could be a source of anxiety or depression.
Twenty two per cent of the study population tested positive for psychiatric disorders using the SRQ-20. Since up to 25% of the normal population could test positive with this mode of assessment, it falls within normal limits. Five out of eight patients that were positive for psychiatric disorders using the HADS had anxiety, while three had depression. This also follows the pattern of distribution of these disorders when normal populations are assessed with these tests. Literature on the psychiatric co-morbidity in glaucoma patients is scanty. In a reported case-control study by means of self-report questionnaire, Roy Wilson et al 9 found no significant difference in depression scores of glaucoma patients and controls. Noteworthy is the fact that they had more male than female representation among their glaucoma study group with the majority of them not working, and being significantly older than their control groups. Furthermore, they found 7.4% prevalence of depression among glaucoma patients as against 13.3-21.4% among their control group who had only cataract. This study and ours suffer similar methodological flaw in that questionnaires never substituted for clinical interview; yet the findings regarding prevalence of depression are strikingly similar: we found 6% prevalence rate for depression. Contrary to the findings of Roy Wilson et al, 9 referred to above, Erb et al 10 in their study of psychiatric manifestations in patients with primary open angle glaucoma, noted that while in-patient glaucoma patients had higher scores on depression than their outpatient counterparts and the cataract control group, the outpatient glaucoma group had statistically significant higher score for psychosomatic complaints. The score on all three parameters (depression, psycho-somatic complaints, and emotional stability) were normal for the cataract patients. Only the inpatient glaucoma group was subjected to a clinical psychiatric interview in this study, thus making comparison of prevalence rates difficult.
The use of two conceptually contrasting questionnaires in our study is noteworthy. The criticism of the SRQ as having high somatic components, which would seem to make for high sensitivity in physically ill patients, is balanced out by the use of the HAD scale, which is devoid of somatic complaints or symptoms. The instrument notwithstanding, prevalence of psychiatric disorder is known to vary markedly and this is partly dependent on the study population. In a particular primary health care centre in Nigeria, using the 12-item general health questionnaire (GHQ-12) and the SRQ-20, prevalence of psychiatric disorder was found to vary from 6.4% to 13.6% in the same patients. 11 Our finding of 22% prevalence rate is similar to the 22.4% reported by Abiodun 7 among his study group. That 52% of our glaucoma patients are elderly (age > 60 years) is in keeping with the known fact about glaucoma as an illness of the aged. While depression is known to be commoner among females, we found all three depressed patients to be male in this study. The smallness of the numbers, coupled with the other finding that the psychopathologic females were older than the males, may make this a spurious finding. It is, however, to be noted for future studies. Of the psychopathologic cases identified in this study, those aged 50 years and above were more depressed while the younger people aged below 50 years suffered more from anxiety disorder. This trend of varying psychopathologic finding with age could well be the result of perceived helplessness and hopelessness among the older population suffering from an "incurable" visual problem; the initial anxiety being the result of efforts to find a final cure to a threatening visual loss after previous disappointing remedies. There is therefore a need to explore the emotional state of glaucoma patients in order to help improve the totality of their quality of life.
This study did not take into consideration the influence of duration of illness in these patients nor the extent of visual field loss prior to the study even though no statistically significant association between visual field loss and depression was found in a previous study. 9 
